- Pharmaceutical companies
- Boehringer Ingelheim
Boehringer Ingelheim
Phone: +21323344368
Fax: 213 23 34 42 13
Web: https://www.mea.boehringer-ingelheim.com
Type | Privately held Kommanditgesellschaft with an Aktiengesellschaft as general partner |
---|---|
Industry | Pharmaceuticals |
Founded | 1885 (1885) in Ingelheim am Rhein, Germany |
Founder | Albert Boehringer |
Headquarters | Ingelheim, Germany |
Area served | Worldwide |
Key people |
|
Products | Pharmaceuticals and Animal Health |
Revenue | €20.6 billion (2021) |
Operating income | €4.7 billion (2021) |
Net income | €3.4 billion (2021) |
Total assets | €40.6 billion (2021) |
Total equity | €19.3 billion (2021) |
Owner | Boehringer, Liebrecht and von Baumbach families |
Number of employees | 52,391 (2021) |
Website | boehringer-ingelheim.com |
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.
For detailed contact information visit location pages below.
Boehringer Ingelheim's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Boehringer Ingelheim
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimRecruitingKidney Disease, ChronicKorea, Republic of
-
Boehringer IngelheimRecruitingDepressive Disorder, MajorUnited States
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Gastrointestinal Cancer | Liver CancerJapan
-
Boehringer IngelheimRecruiting